REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/20/2026
Back to search
Official data from USPTO
SYSNIB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SYSNIB
ST13
US500000079292224Class
5, 9, 10, 42, 44
Filing
79292224
Registration
6422359
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
07/20/2026
Trademark type
Word
Nice classes
5, 9, 10, 42, 44
Filing date
06/18/2020
Registration date
07/20/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/20/2021
Last transaction
07/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
PARKS, KIMBERLY L
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NITTO BOSEKI, CO., LTD.
Representatives
M. Scott Alprin Alprin Law Offices, P.C.
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cancer; drugs for medical purposes for the treatment of cancer; medicines for human purposes for the treatment of cancer; in vitro diagnostic preparations for medical purposes; diagnostic preparations for medical purposes; diagnostic test reagents for medical purposes; biochemical preparations for medical purposes for the treatment of cancer; biological reagents for medical purposes; biological preparations for medical purposes for the treatment of cancer; chemical reagents for medical purposes; reagents for medical purposes; clinical diagnostic reagents for medical purposes; diagnostic agentspreparations and substances for medical purposes; chemical preparations for medicinal purposes for the treatment of cancer; antibodies for medical purposes for the treatment of cancer; diagnostic biomarker reagents for medical purposes
Class 9
Laboratory apparatus and instruments for treating biological tissue for pathological studies; laboratory apparatusinstruments and their structural parts and fittings for treating biological tissue not for medical purposes; laboratory apparatus and instruments for sample pre-treatment system and sample preparation system; measuring and testing machines and instruments for genetic analysis; measuring or testing machines and instrumentsflow cytometerscell-sortersimaging cytometersimaging analyzers; biological cell testing apparatus for laboratory purposes; biological tissue testing apparatus for laboratory purposes
Class 10
Diagnostic apparatus for medical purposes for testing cancer cellscancerous nucleilymphocytesnucleoproteinDNARNA; biological cell testing apparatus for medical and medical diagnostic purposes; biological tissue testing apparatus for medical and medical diagnostic purposes; medical apparatus for clinical diagnosis of cancer; medical apparatus for pathologic diagnosis; medical apparatus and instruments for pathologic examination
Class 42
Genetic testing for scientific research purposes; developmenttestinginspection for quality control purposesresearch of pharmaceuticals and biological preparations; testing of pharmaceuticalsinspection for quality control purposes and medical research in the fields of medical treatment method and technology; medical research; biological research; chemistry serviceschemistry consultationresearch in the fields of biologyoncology and pathology; chemical and biological laboratory servicesbiologicaloncological and pathological research; laboratory research and analysis services in the fields of biologyoncology and pathology
Class 44
Clinical pathological examination and cytological diagnostics for medical purposes; medical testing for diagnostic purposes; medical testing for disease prediction; pathological examination for medical purposes and providing medical information relating thereto; genetic testing for medical purposes; medical and health services relating to DNAgenetics and genetic testing; medical services; medical information
Publications
History of USPTO decisions and trademark events.
27 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/07/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/05/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/05/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/17/2021
FIMP
FINAL DISPOSITION PROCESSED
11/17/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/20/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
07/20/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/04/2021
PUBO
PUBLISHED FOR OPPOSITION
05/04/2021
GPNX
NOTIFICATION PROCESSED BY IB
05/02/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/14/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/14/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/14/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/31/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/30/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/30/2021
RFNT
REFUSAL PROCESSED BY IB
11/14/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/28/2020
RFRR
REFUSAL PROCESSED BY MPU
10/28/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/05/2020
CNRT
NON-FINAL ACTION WRITTEN
10/04/2020
DOCK
ASSIGNED TO EXAMINER
09/22/2020
MAFR
APPLICATION FILING RECEIPT MAILED
08/25/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/21/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/20/2020
Continuous trademark protection
Get notified about every new filing that threatens SYSNIB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.